Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis
Bin Tang,1 Jun Wang,1 Lin-lin Luo,1 Qiu-gen Li,1,* Dan Huang2,* 1Department of Respiratory Medicine, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, No. 92 Aiguo Road, Nanchang, 330006, Jiangxi, China; 2Department of Anesthesiology, The Second Affiliated Hospital o...
Main Authors: | Tang B, Wang J, Luo LL, Li QG, Huang D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-04-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/risks-of-budesonideformoterol-for-the-treatment-of-stable-copd-a-meta--peer-reviewed-article-COPD |
Similar Items
-
Some aspects of application of the combination of formoterol and budesonide: what is changed?
by: A. A. Vizel, et al.
Published: (2019-12-01) -
Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide–formoterol treatment
by: Wang C, et al.
Published: (2017-12-01) -
Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler® Among Patients with Asthma or COPD Switching from Previous Treatment: a Real-World Study of Patient-Reported Outcomes
by: Gabriella Gálffy, et al.
Published: (2019-07-01) -
Is It Really Feasible to Use Budesonide–Formoterol as Needed for Mild Persistent Asthma? A Systematic Review and Meta-Analysis
by: Xiang Tong, et al.
Published: (2021-06-01) -
Cost-effectiveness analysis of budesonide/formoterol (Symbicort(R)) as needed for mild asthma in Malaysia
by: Gopal, VR, et al.
Published: (2021)